25
Participants
Start Date
July 18, 2022
Primary Completion Date
February 28, 2023
Study Completion Date
February 28, 2023
RIST4721
RIST4721 tablets, 100 mg are blue, oval, biconvex film-coated tablets
Placebo
Matching placebo
Virginia Clinical Research, Inc., Norfolk
Florida Academic Centers Research and Education, LLC, Coral Gables
ForCare Clinical Research, Tampa
Cahaba Dermatology & Skin Center, Birmingham
Wright State Physicians, Fairborn
The Indiana Clinical Trials Center, P.C., Plainfield
Progressive Clinical Research, San Antonio
Investigate MD, LLC, Scottsdale
USC IDS Pharmacy, Los Angeles
Beth Israel Deaconess Medical Center, Boston
Enverus Medical Research, Surrey
SKiN Health, Cobourg
Lead Sponsor
Aristea Therapeutics, Inc.
INDUSTRY